| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/26/1995 | EP0630181A4 Nutritional product for trauma and surgery patients. |
| 07/26/1995 | EP0594570B1 Preparations containing colestyramine for reducing lipid levels |
| 07/25/1995 | US5436401 Skin disorders |
| 07/25/1995 | US5436272 Treatment of obesity |
| 07/25/1995 | US5436266 Compounds |
| 07/25/1995 | US5436257 Low toxicity |
| 07/25/1995 | US5436231 Hypertensive agents |
| 07/25/1995 | US5436230 Using growth factor as slimming agent |
| 07/25/1995 | EP0669824A4 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension. |
| 07/25/1995 | CA2139909A1 Crosslinked anion exchange particles and method for producing the particles |
| 07/25/1995 | CA2022323C Excretion of potassium ion by prostanoic acid derivatives |
| 07/25/1995 | CA1336431C Thiazolo(5,4-b)azepine compounds |
| 07/25/1995 | CA1336428C Substituted dibenzocycloheptenimines |
| 07/25/1995 | CA1336410C Products containing a calcium antagonist and a lipid-lowering agent |
| 07/25/1995 | CA1336409C Tumor or cancer cell killing therapy and agents useful therefor |
| 07/25/1995 | CA1336400C Method for treating renal diseases |
| 07/21/1995 | CA2140579A1 Mono- and di-esters from cinnamic acid or one of its derivatives and vitamin c; process for preparing the same and their use as antioxidants in cosmetic, pharmaceutical or food compositions |
| 07/20/1995 | WO1995019570A1 Antagonists to insulin receptor tyrosine kinase inhibitor |
| 07/20/1995 | WO1995019430A1 Macroencapsulated secretory cells |
| 07/20/1995 | WO1995019384A1 Crosslinked polymeric ammonium salts |
| 07/20/1995 | WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 07/20/1995 | WO1995019180A1 Anti-gram-positive bacterial methods and materials |
| 07/20/1995 | WO1995019170A1 Application of riluzole in the treatment of mitochondrial diseases |
| 07/20/1995 | CA2179383A1 Antagonists to insulin receptor tyrosine kinase inhibitor |
| 07/19/1995 | EP0663407A1 Process for preparation of reconstituted lipoproteins |
| 07/19/1995 | EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 07/19/1995 | EP0662962A1 Substituted pyrimidines for control of diabetic complications |
| 07/19/1995 | EP0662948A1 2-amino-4-phenyl-4-oxo-butyric acid derivatives with kynureninase and/or kynurenine-3-hydroxylase inhibiting activity |
| 07/19/1995 | EP0662837A1 Use of il-10 to prevent or treat insulin-dependent diabetes mellitus |
| 07/19/1995 | EP0662830A1 $g(p)-BOND AROMATIC VITAMIN CHELATES |
| 07/19/1995 | CN1105362A Methods for lowering serum cholesterol |
| 07/19/1995 | CA2140498A1 Method for preventing or reducing risk of onset of cardiovascular events employing an hmg coa reductase |
| 07/18/1995 | US5434287 Bifunctional DTPA-type ligand |
| 07/18/1995 | US5434245 Osteocalcin |
| 07/18/1995 | US5434184 Chemical compounds |
| 07/18/1995 | US5434173 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
| 07/18/1995 | US5434141 Medicament for the treatment of hyperlipidaemia and/or atherosclerosis |
| 07/13/1995 | WO1995018803A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | WO1995018620A1 Treatment using arachidonic acid metabolite and particulate formulations |
| 07/13/1995 | WO1995018618A2 Enteral formula with ribo-nucleotides |
| 07/13/1995 | WO1995018614A1 Method for treatment of obesity using prolactin modulators and diet |
| 07/13/1995 | CA2180360A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
| 07/13/1995 | CA2180340A1 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof |
| 07/13/1995 | CA2179986A1 Treatment using arachidonic acid metabolite and particulate formulations |
| 07/12/1995 | EP0662481A1 Spiro piperidines and homologs promote release of growth hormone |
| 07/12/1995 | EP0662479A2 Non-reducing oligosaccharide with neotrehalose structure, and its production and uses |
| 07/12/1995 | EP0662471A2 Naphthalene derivatives with affinity to the receptors of melatonine, process for their preparation and pharmaceutical compositions containing them |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0662075A1 Prostaglandin analog for treating osteoporosis |
| 07/12/1995 | EP0661992A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 07/12/1995 | EP0661991A1 Methods for treating renin-related disorders with amylin antagonists |
| 07/12/1995 | EP0661990A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 07/12/1995 | EP0661933A1 Morphogen-enriched dietary composition |
| 07/12/1995 | EP0661927A1 A process for producing beta-casein enriched products |
| 07/12/1995 | EP0623027A4 Methods of terminating pregnancy. |
| 07/12/1995 | CN1104890A Cation-complexed polysacharides |
| 07/11/1995 | US5432166 Use of 1-(β-D-arabinofuranosyl) -5-propynyluracil for lowering serum cholesterol |
| 07/11/1995 | US5432161 Replacement for ascorbic acid |
| 07/11/1995 | US5432160 Contains beta-alanyl-L-glutamine |
| 07/11/1995 | US5431925 Nutritive composition for prevention and therapy of infection diseases caused by immunosuppression |
| 07/11/1995 | CA1336287C Selective serotonin uptake inhibitors |
| 07/06/1995 | WO1995018221A1 Gene coding for adseverins |
| 07/06/1995 | WO1995018153A1 Glucagon analogs with serine replacements at position 16 having antagonistic activity |
| 07/06/1995 | WO1995018152A1 Derivatized calcitonins |
| 07/06/1995 | WO1995018141A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration |
| 07/06/1995 | WO1995018128A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | WO1995018097A1 Anthranilic acid derivative |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017905A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | WO1995017902A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based on it with adaptogenic and immunomodulating properties |
| 07/06/1995 | WO1995017901A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | CA2180359A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | CA2180260A1 Methods and compositions for the treatment of a host with a cellular proliferative disease |
| 07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
| 07/06/1995 | CA2155662A1 Anthranilic acid derivative |
| 07/05/1995 | EP0661051A2 Medicament for the treatment of perfusion changes |
| 07/05/1995 | EP0660707A1 Method of preventing nmda receptor-mediated neuronal damage |
| 07/05/1995 | EP0660706A1 Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol |
| 07/05/1995 | EP0660676A1 Novel compositions. |
| 07/04/1995 | US5430144 E.g, N-(1-((2'-((methoxycarbonyl)amino)(1,1'-biphenyl)-4-yl) methyl)-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepin-3-yl)-3 ((fur-2-yl)methyl)amino-3-methylbutanamide |
| 07/04/1995 | US5430116 Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 07/04/1995 | US5430110 Polyvinylamine derivatives having hydrophilic centers, processes for their preparation and the use of the compounds as a medicament, active compound carrier and foodstuff auxiliary |
| 07/04/1995 | US5430065 Orally or parenterally administering carnitine, acylcarnitine or salt thereof |
| 07/04/1995 | US5430060 Aldose reductase inhibitor |
| 07/04/1995 | CA1336195C Aryloxyphenylpropylamines and their preparation and use |
| 07/04/1995 | CA1336168C Method of preventing or treating toxemia in pregnancy using a thromboxane a_ receptor antagonist |
| 07/01/1995 | CA2138878A1 Thinning composition making use of two types of liposomes for topical application, its use |
| 06/29/1995 | WO1995017423A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | WO1995017422A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | WO1995017405A1 Indoline derivatives, method of preparation and their use as pharmaceuticals |
| 06/29/1995 | WO1995017379A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors |
| 06/29/1995 | WO1995017207A1 Parathyroid hormone formulation |
| 06/29/1995 | WO1995017197A1 Vitamin d3 analogues and pathway to mediate disorders |
| 06/29/1995 | WO1995017182A1 Protein kinase c inhibitors |
| 06/29/1995 | WO1995017164A1 A pharmaceutical composition for the intranasal administration of hydroxocobalamin |
| 06/29/1995 | CA2179598A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | CA2179597A1 Compounds with growth hormone releasing properties |
| 06/29/1995 | CA2179402A1 Indoline derivatives, method of preparation and their use as pharmaceuticals |
| 06/29/1995 | CA2179288A1 Vitamin d3 analogues and pathway to mediate disorders |
| 06/29/1995 | CA2178833A1 Phenylthiophenyl cycloalkenyl hydroxyureas as lipoxygenase inhibitors |